In this episode, three pharmaceutical industry experts help us explore the key pressure points in the sector. Joel Lexchin is a Professor Emeritus in the Faculty of Health at York University in Toronto, Canada. He has authored and co-authored over 140 peer-reviewed papers on a wide range of pharmaceutical topics, from research and development to drug promotion and medicine regulation.Claudia Martínez is the Head of Research at the Access to Medicine Foundation, a non-profit organisation that seeks to address the availability and affordability of medicine to promote equitable access.Andy Powrie-Smith is the Executive Director of Communications and Partnerships at the European Federation of Pharmaceutical Industries and Associations (EFPIA), a trade body representing pharmaceutical research-based firms across Europe.Good Corp, Bad Corp is produced by Speak Productions. The views expressed in this episode represent the interviewees’ own opinions and may not be shared by the podcast host or the production company. Speak Productions has no affiliation with the interviewees and has not paid guests to participate. Care was taken to ensure the accuracy of facts within the episode. This podcast is for informational purposes only. Thanks for listening to Good Corp, Bad Corp. If you enjoyed today’s episode, please remember to subscribe to our podcast, rate the episode and leave a review on your favourite podcast platform. And if you have ideas for future episodes, please get in touch via LinkedIn or at [email protected].~Speak Productions’ factchecking process highlighted additional statistics or indicated potential inconsistencies between information referenced in the podcast and online sources, which have been noted below.• • • •